The table below shows Nuvation Bio Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$83.23M
$13.12M
$4.83M
$3.08M
$727.00K
$1.44M
Cost of revenue
-
$3.35M
$2.58M
$2.09M
$1.51M
$1.35M
Gross profit
-
$9.77M
$2.26M
$990.00K
-$788.00K
$88.00K
R&D
$35.05M
$28.85M
$27.36M
$24.60M
$27.73M
$29.25M
NUVB annual revenue (10-K history)
Nuvation Bio Inc. reported annual revenue of $62.90M for fiscal year 2025. That is up 699.0% from $7.87M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.